Inv(16) may be one of the only ‘favorable’ factors in acute myeloid leukemia: A report on 19 cases with prolonged follow-up
- 1 December 1994
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 18 (12) , 885-888
- https://doi.org/10.1016/0145-2126(94)90098-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 GroupBlood, 1993
- Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]Blood, 1992
- Chromosome 16 abnormalities associated with myeloid malignanciesGenes, Chromosomes and Cancer, 1991
- Acute myelogenous leukemia with an 8;21 translocationCancer Genetics and Cytogenetics, 1990
- Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 casesBritish Journal of Haematology, 1989
- Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemiaBlood, 1989
- Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: A study of 343 patientsCancer Genetics and Cytogenetics, 1987
- Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosisBlood, 1986
- Predictors of Response of Acute Nonlymphocytic LeukemiaCancer Investigation, 1986
- A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22)Blood, 1985